Literature DB >> 2654122

Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

G B Elion1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2654122     DOI： 10.1007/bf02624593

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN： 0883-8364


× No keyword cloud information.
  127 in total

1.  6-Mercaptopurine: effects in mouse sarcoma 180 and in normal animals.

Authors:  D A CLARKE; F S PHILIPS; S S STERNBERG; C C STOCK; G B ELION; G H HITCHINGS
Journal:  Cancer Res       Date:  1953-08       Impact factor: 12.701

2.  Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.

Authors:  J A Fyfe; P M Keller; P A Furman; R L Miller; G B Elion
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

3.  The limitations of inhibition analysis.

Authors:  G H HITCHINGS; G B ELION; H VANDERWERFF
Journal:  J Biol Chem       Date:  1948-07       Impact factor: 5.157

4.  Antagonists of nucleic acid derivatives. IV. Reversal studies with 2-aminopurine and 2,6-diaminopurine.

Authors:  G B ELION; G H HITCHINGS
Journal:  J Biol Chem       Date:  1950-12       Impact factor: 5.157

5.  The 12th Report of the Human Renal Transplant Registry. Prepared by the Advisory Committee to the Renal Transplant Registry.

Authors: 
Journal:  JAMA       Date:  1975-08-18       Impact factor: 56.272

6.  Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.

Authors:  P A Furman; M H St Clair; J A Fyfe; J L Rideout; P M Keller; G B Elion
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

Review 7.  Overview of acyclovir pharmacokinetic disposition in adults and children.

Authors:  M R Blum; S H Liao; P de Miranda
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

8.  Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

Authors:  B Sköldenberg; M Forsgren; K Alestig; T Bergström; L Burman; E Dahlqvist; A Forkman; A Frydén; K Lövgren; K Norlin
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

9.  Metabolic disposition of acyclovir in the guinea pig, rabbit, and monkey.

Authors:  S S Good; P de Miranda
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

10.  Conversion of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine to acyclovir as catalyzed by adenosine deaminase.

Authors:  T Spector; T E Jones; L M Beacham
Journal:  Biochem Pharmacol       Date:  1983-09-01       Impact factor: 5.858
View more
  8 in total

1.  Case Report: Azathioprine: An Old and Wronged Immunosuppressant.

Authors:  Pedro R Chocair; Precil Diego Miranda de Menezes Neves; Sara Mohrbacher; Maurilio Pacheco Neto; Victor A H Sato; Érico S Oliveira; Leonardo V Barbosa; Alessandra M Bales; Fagner Pereira da Silva; Américo L Cuvello-Neto; John A Duley
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 2.  Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.

Authors:  Marçal Pastor-Anglada; Sandra Pérez-Torras
Journal:  Front Pharmacol       Date:  2015-02-10       Impact factor: 5.810

Review 3.  Addressing the selectivity and toxicity of antiviral nucleosides.

Authors:  Joy Y Feng
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

Review 4.  Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides.

Authors:  Elodie Villa; Eunus S Ali; Umakant Sahu; Issam Ben-Sahra
Journal:  Cancers (Basel)       Date:  2019-05-17       Impact factor: 6.639

5.  Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia.

Authors:  Melissa Zhang; Bruce Bostrom
Journal:  F1000Res       Date:  2019-02-11

Review 6.  Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster.

Authors:  Kimiyasu Shiraki; Shinichiro Yasumoto; Nozomu Toyama; Hiroaki Fukuda
Journal:  Viruses       Date:  2021-08-05       Impact factor: 5.048

7.  Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United States.

Authors:  T Sokka; T Pincus
Journal:  Rheumatology (Oxford)       Date:  2008-08-07       Impact factor: 7.580

Review 8.  BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease.

Authors:  Raymond Taylor; Pravin Kotian; Travis Warren; Rekha Panchal; Sina Bavari; Justin Julander; Sylvia Dobo; Angela Rose; Yahya El-Kattan; Brian Taubenheim; Yarlagadda Babu; William P Sheridan
Journal:  J Infect Public Health       Date:  2016-04-16       Impact factor: 3.718
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.